Development of [225Ac]Ac-PSMA-I&T for Targeted Alpha Therapy According to GMP Guidelines for Treatment of mCRPC
Hooijman, Eline L., Chalashkan, Yozlem, Ling, Sui Wai, Kahyargil, Figen F., Segbers, Marcel, Bruchertseifer, Frank, Morgenstern, Alfred, Seimbille, Yann, Koolen, Stijn L. W., Brabander, Tessa, de Blois, Erik
Published in Pharmaceutics (13.05.2021)
Published in Pharmaceutics (13.05.2021)
Get full text
Journal Article
Implementing Ac-225 labelled radiopharmaceuticals: practical considerations and (pre-)clinical perspectives
Hooijman, Eline L., Radchenko, Valery, Ling, Sui Wai, Konijnenberg, Mark, Brabander, Tessa, Koolen, Stijn L. W., de Blois, Erik
Published in EJNMMI radiopharmacy and chemistry (06.02.2024)
Published in EJNMMI radiopharmacy and chemistry (06.02.2024)
Get full text
Journal Article
Radiolabeling and quality control of therapeutic radiopharmaceuticals: optimization, clinical implementation and comparison of radio-TLC/HPLC analysis, demonstrated by [177Lu]Lu-PSMA
Hooijman, Eline L., Ntihabose, Carolline M., Reuvers, Thom G. A., Nonnekens, Julie, Aalbersberg, Else A., van de Merbel, Jordy R. J. P., Huijmans, Judith E., Koolen, Stijn L. W., Hendrikx, Jeroen J. M. A., de Blois, Erik
Published in EJNMMI radiopharmacy and chemistry (04.11.2022)
Published in EJNMMI radiopharmacy and chemistry (04.11.2022)
Get full text
Journal Article
Evaluation of the tolerability and safety of 225AcAc-PSMA-I&T in patients with metastatic prostate cancer: a phase I dose escalation study
Ling, Sui Wai, van der Veldt, Astrid A M, Konijnenberg, Mark, Segbers, Marcel, Hooijman, Eline, Bruchertseifer, Frank, Morgenstern, Alfred, de Blois, Erik, Brabander, Tessa
Published in BMC cancer (29.01.2024)
Published in BMC cancer (29.01.2024)
Get full text
Journal Article
Evaluation of the tolerability and safety of [ 225 Ac]Ac-PSMA-I&T in patients with metastatic prostate cancer: a phase I dose escalation study
Ling, Sui Wai, van der Veldt, Astrid A M, Konijnenberg, Mark, Segbers, Marcel, Hooijman, Eline, Bruchertseifer, Frank, Morgenstern, Alfred, de Blois, Erik, Brabander, Tessa
Published in BMC cancer (29.01.2024)
Published in BMC cancer (29.01.2024)
Get full text
Journal Article
SSP-14 - Development of alpha particle emitting radionuclide therapy according to GMP guidelines for treatment of mCRPC
Hooijman, Eline, Chalashkan, Yozlem, Ling, Sui, Kahyargil, Figen, Bruchertseifer, Frank, Morgenstern, Alfred, Seimbille, Yann, Koolen, Stijn, Brabander, Tessa, de Blois, Erik
Published in Nuclear medicine and biology (01.05.2021)
Published in Nuclear medicine and biology (01.05.2021)
Get full text
Journal Article
Development of alpha particle emitting radionuclide therapy according to GMP guidelines for treatment of mCRPC
Hooijman, Eline, Chalashkan, Yozlem, Ling, Sui, Kahyargil, Figen, Bruchertseifer, Frank, Morgenstern, Alfred, Seimbille, Yann, Koolen, Stijn, Brabander, Tessa, de Blois, Erik
Published in Nuclear medicine and biology (01.05.2021)
Published in Nuclear medicine and biology (01.05.2021)
Get full text
Journal Article
Evaluation of the tolerability and safety of [225Ac]Ac-PSMA-I T in patients with metastatic prostate cancer: a phase I dose escalation study
Sui wai Ling, Astrid A. M. van der Veldt, Mark Konijnenberg, Marcel Segbers, Eline Hooijman, Frank Bruchertseifer, Alfred Morgenstern, Erik de Blois, Tessa Brabander
Published in BMC cancer (01.01.2024)
Published in BMC cancer (01.01.2024)
Get full text
Journal Article
Development of [225Ac]Ac-PSMA-I T for Targeted Alpha Therapy According to GMP Guidelines for Treatment of mCRPC
Eline L. Hooijman, Yozlem Chalashkan, Sui Wai Ling, Figen F. Kahyargil, Marcel Segbers, Frank Bruchertseifer, Alfred Morgenstern, Yann Seimbille, Stijn L. W. Koolen, Tessa Brabander, Erik de Blois
Published in Pharmaceutics (01.05.2021)
Published in Pharmaceutics (01.05.2021)
Get full text
Journal Article